DiscoverMarkets & Money Today | 2 Min News | The Daily News Now!Merck tops estimates on Keytruda strength and narrows profit outlook, as it lowers estimated tariff hit
Merck tops estimates on Keytruda strength and narrows profit outlook, as it lowers estimated tariff hit

Merck tops estimates on Keytruda strength and narrows profit outlook, as it lowers estimated tariff hit

Update: 2025-10-30
Share

Description

Merck's Q3 earnings soar, driven by Keytruda's record sales, reaching $8B for the first time. Despite patent expiration in 2028, Merck plans to cut $3B in costs by 2027. Gardasil sales drop in China, but meet expectations. Animal health segment surges 16% with strong livestock product demand.

The Daily News Now! — Every city. Every story. AI-powered.


Hosted on Acast. See acast.com/privacy for more information.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Merck tops estimates on Keytruda strength and narrows profit outlook, as it lowers estimated tariff hit

Merck tops estimates on Keytruda strength and narrows profit outlook, as it lowers estimated tariff hit